Pediatric Obesity: Complications and Current Day Management

Ожирение у детей: осложнения и современные подходы к лечению
Silva A Arslanian, Mary Ellen Vajravelu, Emir Tas
2023-07-20

Anti-obesity medicationsMetabolic and bariatric surgeryMetabolic complicationsPediatric obesitySetmelanotide
Obesity affects approximately 1 in 5 youth globally and increases the risk of complications during adolescence and young adulthood, including type 2 diabetes, dyslipidemia, hypertension, non-alcoholic fatty liver disease, obstructive sleep apnea, and polycystic ovary syndrome. Children and adolescents with obesity frequently experience weight stigma and have an impaired quality of life, which may exacerbate weight gain. Pediatric obesity is typically defined using sex-, age-, and population-specific body mass index percentiles. Once identified, pediatric obesity should always be managed with lifestyle modification. However, adolescents with obesity may also benefit from anti-obesity medications (AOM), several of which have been approved for use in adolescents by the US Food and Drug Administration, including liraglutide, phentermine/topiramate, and semaglutide. For children with specific, rare monogenic obesity disorders, setmelanotide is available and may lead to significant weight loss. Metabolic and bariatric surgery may be used for the management of severe obesity in youth; though highly effective, it is limited to specialized centers and has had relatively low pediatric uptake. In this narrative review using pediatric-focused data from original research, reviews, clinical practice guidelines, governmental agencies, and pharmaceutical companies, we review obesity-related metabolic complications in youth and management strategies, including AOM and bariatric surgery.
1
Adolescents with obesity may benefit from FDA-approved anti-obesity medications, including liraglutide, phentermine/topiramate, and semaglutide.
2
Approximately one in five youth globally has obesity, which increases risks of type 2 diabetes, dyslipidemia, hypertension, fatty liver disease, sleep apnea, and polycystic ovary syndrome.
3
Metabolic and bariatric surgery is highly effective for severe pediatric obesity but remains limited by specialized-center availability and low uptake.
4
Pediatric obesity is defined using sex-, age-, and population-specific BMI percentiles and should always be managed initially with lifestyle modification.
5
Setmelanotide may produce significant weight loss in children with specific rare monogenic obesity disorders.
6
Weight stigma and impaired quality of life are common in youth with obesity and may further contribute to weight gain.

pediatric obesity in children and adolescents

obesity-related metabolic complications and management strategies, including lifestyle modification, anti-obesity medications, and metabolic and bariatric surgery

Publication Details
Publication Date
2023-07-20
Journal
Publisher
ISSN
Cited by
64
Access Type
Author Information
Authors
Silva A Arslanian
Mary Ellen Vajravelu
Emir Tas
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%